<DOC>
	<DOCNO>NCT00309413</DOCNO>
	<brief_summary>The purpose study determine whether cannabidiol , herbal cannabinoid , effective treatment acute schizophrenic schizophreniform psychosis placebo-controlled , randomize double-blind study .</brief_summary>
	<brief_title>A Clinical Trial Antipsychotic Properties Cannabidiol</brief_title>
	<detailed_description>Despite recent advance treatment schizophrenia schizophreniform disorder , still need develop efficient well tolerate psychopharmacological approach group diseases . The endogenous cannabinoid system provide promising target pharmacotherapy disorder . This approach base upon recent finding indicate human endogenous cannabinoid system significantly involve pathogenesis schizophrenia cannabidiol effective treat acute psychotic symptom schizophrenic patient . We investigate cannabidiol versus placebo randomize , double blind design extensive safety measure . The primary hypothesis test Cannabidiol expect superior placebo treatment acute schizophrenic schizophreniform psychoses regard antipsychotic efficacy .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>DSMIV Diagnosis schizophrenic schizophreniform psychosis Minimal initial score 36 BPRS total score minimum 12 BPRS Psychosis Cluster , include item 4 ( conceptional disorganisation ) , 8 ( exaggerated selfesteem ) , 12 ( hallucinatory behaviour ) , 15 ( unusual thought content ) Exclusion pregnancy female subject negative Î²HCG test Lack accountability Pregnancy risk pregnancy lactation . Other relevant interference axis 1 accord diagnostic evaluation MINI include undifferentiated residual form schizophrenia . Treatment depotantipsychotics last three month . Severe internal neurological illness , especially cardiovascular , renal , advanced respiratory , haematological endocrinological failure . Positive Hepatitisserology . QTcelongation . Acute suicidal tendency hazard others patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Schizophrenia Disorders Psychotic Features</keyword>
</DOC>